Arrhythmogenic right ventricular cardiomyopathy;Die arrhythmogene rechtsventrikuläre kardiomyopathie

Herz

Volumn 30, Issue 6, 2005, Pages 565-570

  Haverkamp, Wilhelm ^a   Rolf, Sascha ^a   Osterziel, Karl Josef ^a   Dietz, Rainer ^a   Peters, Stefan ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Arrhythmias; Arrhythmogenic right ventricular cardiomyopathy; Cardiomyopathy; Implantable cardioverter defibrillator; Right ventricle; Right ventricular dysplasia; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

ADIPOSE TISSUE; ARTICLE; ATHLETE; CLINICAL FEATURE; DEFIBRILLATOR; ECG ABNORMALITY; FAMILY; GENETIC HETEROGENEITY; GENETIC IDENTIFICATION; HEART ELECTROPHYSIOLOGY; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; LIPOMATOSIS; MUSCLE ATROPHY; OUTPATIENT DEPARTMENT; PATIENT SELECTION; RECOGNITION; SUDDEN DEATH;

ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOMYOPATHIES; CARDIOMYOPATHY, RESTRICTIVE; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS;

EID: 25444488967     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2733-2     Document Type: Article

References (40)

1. Marcus FI, Fontaine G, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 cases. Circulation 1982;65:384-99.
2. Marcus FI, Fontaine G. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a review. Pacing Clin Electrophysiol 1995;18:1298-314.
3. Wichter T, Borggrefe M, Breithardt G. Die arrhythmogene rechtsventrikuläre Kardiomyopathie: Ätiologie, Diagnostik und Therapie. Med Klin 1998;93:268-77.
4. Corrado D, Basso C, Thiene G. Arrhythmogenic right ventricular cardiomyopathy:diagnosis, prognosis, and treatment. Heart 2000;83:588-95.
5. Frank R, Fontaine G, Vedel J. Electrocardiologie de quatre cas de dysplasie ventriculaire droite arrythmogène. Arch Mal Coeur Vaiss 1978;71:963-72.
6. Richardson P, McKenna W, Bristow M, et al. Report of the World Health Organisation/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1995;93:841-2.
7. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventircular cardiomyopathy. J Am Coll Cardiol 2000;36:2226-33.
8. Marcus F, Towbin JA, Zareba W, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). A multidisciplinary study: design and protocol. Circulation 2003;107:2975-8.
9. Nava A, Thiene G, Canciani B, et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 1988;12:1222-8.
10. Coonar AS, Protonotarios N, Tsatsopoulou A. et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58.
11. Fontaine G, Gallais Y, Fornes P, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy. Anesthesiology 2001;95:250-4.
12. Peters S, Trummel M, Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int J Cardiol 2004;97:499-501.
13. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988;318:129-33.
14. Marcus FI. Is arrhythmogenic right ventricular dysplasia, Uhl's anomaly, and right ventricular outflow tract tachycardia a spectrum of the same disease? Cardiol Rev 1997;5:25-9.
15. Boulos M, Lashevsky I, Reisner S, et al. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J Am Coll Cardiol 2001;38:2020-7.
16. Wichter T, Hindricks G, Lerch H, et al. Regional myocardial sympathetic dysinnervation in arrhythmogenic right ventricular cardiomyopathy: an analysis using 123I-meta-iodobenzylguanidine scintigraphy. Circulation 1994;89:667-83.
17. Paul M, Schulze-Bahr E, Breithardt G, et al. Genetics of arrhythmogenic right ventricular cardiomyopathy - status quo and future perspectives. Z Kardiol 2003;92:128-36.
18. McKoy G, Protonotarios N, Crosby A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
19. Rampazzo A, Nava A, Malacrida S, et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet 2002;71:1200-6.
20. Alcalai R, Metzger S, Rosen heck S, et al. A recessive mutation in desmoplakin causes arrhythmogenic right ventricular dysplasia, skin disorder and woolly hair. J Am Coll Cardiol 2003;42:319-27.
21. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-4.
22. Tiso N, Stephan DA, Nava A, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10:189-94.
23. Beffagna G, Occhi G, Nava A, et al. Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res 2005;65:366-73.
24. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-8.
25. O'Donnell D, Cox D, Bourke J, et al. Clinical and electro-physiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J 2003;24:801-10.
26. Turrini P, Corrado D, Basso C, et al. Noninvasive risk stratification in arrhythmogenic right ventricular cardiomyopathy. Ann Noninvasive Electrocardiol 2003;8:161-9.
27. Peters S, Trummel M. Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann Noninvasive Electrocardiol 2003;8:238-45.
28. Yoshioka N, Tsuchihashi K, Yuda S, et al. Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and in their pedigrees. Am J Cardiol 2000;85:885-9.
29. Peters S, Trümmel M, Brattström A, et al. Lokalisierte rechtspräkordiale QRS-Prolongation als diagnostisches Kriterium der arrhythmogenen rechtsventrikulären Dysplasie-Kardiomyopathie: Tatsache oder Messfehler? J Kardiol 2003;10:200-3.
30. Nasir K, Rutberg J, Tandri H, et al. Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann Noninvasive Electrocardiol 2003;8:112-20.
31. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-50.
32. Lindstrom L, Wilkenshoff UM, Larsson H, et al. Echocardiographic assessment of arrhythmogenic right ventricular cardiomyopathy. Heart 2001;86:31-8.
33. Blake LM, Scheinmann MM, Hinggis CB. MR features of arrhythmogenic right ventricular dysplasia. AJR Am J Roentgenol 1994;162:809-12.
34. Tandri H, Friedrich MG, Calkins H, et al. MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia. J Cardiovasc Magn Reson 2004;6:557-63.
35. Wichter T, Paul TM, Eckardt L, et al. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD? Herz 2005;30:91-101.
36. Wichter T, Borggrefe M, Haverkamp W, et al. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 1992;86:29-37.
37. Corrado D, Basso C, Nava A, et al. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol Rev 2001;9:259-65.
38. Corrado D, Leoni L, Link MS, et al. Implantable cardioverter- defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 2003;108:3084-91.
39. Wichter T, Paul M, Wollmann C, et al. Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients.Circulation 2004;109:1503-8.
40. Hodgkinson KA, Parfrey PS, Bassett AS, et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J Am Coll Cardiol 2005;45:400-8.